These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 25198388)

  • 1. The design and synthesis of potent and selective inhibitors of Trypanosoma brucei glycogen synthase kinase 3 for the treatment of human african trypanosomiasis.
    Urich R; Grimaldi R; Luksch T; Frearson JA; Brenk R; Wyatt PG
    J Med Chem; 2014 Sep; 57(18):7536-49. PubMed ID: 25198388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indirubin Analogues Inhibit
    Efstathiou A; Gaboriaud-Kolar N; Myrianthopoulos V; Vougogiannopoulou K; Subota I; Aicher S; Mikros E; Bastin P; Skaltsounis AL; Soteriadou K; Smirlis D
    Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30910902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel 1,2-dihydroquinazolin-2-ones: Design, synthesis, and biological evaluation against Trypanosoma brucei.
    Pham T; Walden M; Butler C; Diaz-Gonzalez R; Pérez-Moreno G; Ceballos-Pérez G; Gomez-Pérez V; García-Hernández R; Zecca H; Krakoff E; Kopec B; Ichire O; Mackenzie C; Pitot M; Ruiz LM; Gamarro F; González-Pacanowska D; Navarro M; Dounay AB
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3629-3635. PubMed ID: 28729055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycogen synthase kinase 3 is a potential drug target for African trypanosomiasis therapy.
    Ojo KK; Gillespie JR; Riechers AJ; Napuli AJ; Verlinde CL; Buckner FS; Gelb MH; Domostoj MM; Wells SJ; Scheer A; Wells TN; Van Voorhis WC
    Antimicrob Agents Chemother; 2008 Oct; 52(10):3710-7. PubMed ID: 18644955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From on-target to off-target activity: identification and optimisation of Trypanosoma brucei GSK3 inhibitors and their characterisation as anti-Trypanosoma brucei drug discovery lead molecules.
    Woodland A; Grimaldi R; Luksch T; Cleghorn LA; Ojo KK; Van Voorhis WC; Brenk R; Frearson JA; Gilbert IH; Wyatt PG
    ChemMedChem; 2013 Jul; 8(7):1127-37. PubMed ID: 23776181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-myristoyltransferase inhibitors as new leads to treat sleeping sickness.
    Frearson JA; Brand S; McElroy SP; Cleghorn LA; Smid O; Stojanovski L; Price HP; Guther ML; Torrie LS; Robinson DA; Hallyburton I; Mpamhanga CP; Brannigan JA; Wilkinson AJ; Hodgkinson M; Hui R; Qiu W; Raimi OG; van Aalten DM; Brenk R; Gilbert IH; Read KD; Fairlamb AH; Ferguson MA; Smith DF; Wyatt PG
    Nature; 2010 Apr; 464(7289):728-32. PubMed ID: 20360736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benzodipyrazoles: a new class of potent CDK2 inhibitors.
    D'Alessio R; Bargiotti A; Metz S; Brasca MG; Cameron A; Ermoli A; Marsiglio A; Polucci P; Roletto F; Tibolla M; Vazquez ML; Vulpetti A; Pevarello P
    Bioorg Med Chem Lett; 2005 Mar; 15(5):1315-9. PubMed ID: 15713378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of potent and selective inhibitors of Trypanosoma brucei ornithine decarboxylase.
    Smithson DC; Lee J; Shelat AA; Phillips MA; Guy RK
    J Biol Chem; 2010 May; 285(22):16771-81. PubMed ID: 20220141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trypanosoma brucei glycogen synthase kinase-3, a target for anti-trypanosomal drug development: a public-private partnership to identify novel leads.
    Oduor RO; Ojo KK; Williams GP; Bertelli F; Mills J; Maes L; Pryde DC; Parkinson T; Van Voorhis WC; Holler TP
    PLoS Negl Trop Dis; 2011 Apr; 5(4):e1017. PubMed ID: 21483717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of novel inhibitors of UDP-Glc 4'-epimerase, a validated drug target for african sleeping sickness.
    Urbaniak MD; Tabudravu JN; Msaki A; Matera KM; Brenk R; Jaspars M; Ferguson MA
    Bioorg Med Chem Lett; 2006 Nov; 16(22):5744-7. PubMed ID: 16962325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Towards the development of novel Trypanosoma brucei RNA editing ligase 1 inhibitors.
    Durrant JD; McCammon JA
    BMC Pharmacol; 2011 Aug; 11():9. PubMed ID: 21878090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel bis(indolyl)maleimide pyridinophanes that are potent, selective inhibitors of glycogen synthase kinase-3.
    Zhang HC; Boñaga LV; Ye H; Derian CK; Damiano BP; Maryanoff BE
    Bioorg Med Chem Lett; 2007 May; 17(10):2863-8. PubMed ID: 17350261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and biological evaluation of Trypanosoma brucei trypanothione synthetase inhibitors.
    Spinks D; Torrie LS; Thompson S; Harrison JR; Frearson JA; Read KD; Fairlamb AH; Wyatt PG; Gilbert IH
    ChemMedChem; 2012 Jan; 7(1):95-106. PubMed ID: 22162199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-based approaches to improve selectivity: CDK2-GSK3beta binding site analysis.
    Vulpetti A; Crivori P; Cameron A; Bertrand J; Brasca MG; D'Alessio R; Pevarello P
    J Chem Inf Model; 2005; 45(5):1282-90. PubMed ID: 16180905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Four-Point Screening Method for Assessing Molecular Mechanism of Action (MMOA) Identifies Tideglusib as a Time-Dependent Inhibitor of Trypanosoma brucei GSK3β.
    Swinney ZT; Haubrich BA; Xia S; Ramesha C; Gomez SR; Guyett P; Mensa-Wilmot K; Swinney DC
    PLoS Negl Trop Dis; 2016 Mar; 10(3):e0004506. PubMed ID: 26942720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computer-aided discovery of Trypanosoma brucei RNA-editing terminal uridylyl transferase 2 inhibitors.
    Demir O; Labaied M; Merritt C; Stuart K; Amaro RE
    Chem Biol Drug Des; 2014 Aug; 84(2):131-9. PubMed ID: 24903413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery and antiparasitic activity of AZ960 as a Trypanosoma brucei ERK8 inhibitor.
    Valenciano AL; Ramsey AC; Santos WL; Mackey ZB
    Bioorg Med Chem; 2016 Oct; 24(19):4647-4651. PubMed ID: 27519462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Vitro and In Vivo Investigation of the Inhibition of Trypanosoma brucei Cell Growth by Lipophilic Bisphosphonates.
    Yang G; Zhu W; Kim K; Byun SY; Choi G; Wang K; Cha JS; Cho HS; Oldfield E; No JH
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7530-9. PubMed ID: 26392508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computer-aided identification of Trypanosoma brucei uridine diphosphate galactose 4'-epimerase inhibitors: toward the development of novel therapies for African sleeping sickness.
    Durrant JD; Urbaniak MD; Ferguson MA; McCammon JA
    J Med Chem; 2010 Jul; 53(13):5025-32. PubMed ID: 20527952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of potent inhibitors of the Trypanosoma brucei methionyl-tRNA synthetase via high-throughput orthogonal screening.
    Pedró-Rosa L; Buckner FS; Ranade RM; Eberhart C; Madoux F; Gillespie JR; Koh CY; Brown S; Lohse J; Verlinde CL; Fan E; Bannister T; Scampavia L; Hol WG; Spicer T; Hodder P
    J Biomol Screen; 2015 Jan; 20(1):122-30. PubMed ID: 25163684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.